Belogent cream for external use, 30 g
Dosage:
0.05% x 15g
0.05% x 30g
0.05% x 40g
0.05% + 0.1% x 30g
0.05% + 0.1% x 40g
0.05% + 0.1% x 5g
1 g of cream contains 0.64 mg betamethasone dipropionate (corresponding to 0.5 mg betamethasone), gentamicin sulfate (based on base) 1 mg
Release form:
Cream
Ointment
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Cream
Manufacturer country
Croatia
Package quantity, pcs
one
Belogent cream for plank beds.
approx. 30g
Name ENG
BELOGENT
Clinical and pharmacological group
Drug with antibacterial and anti-inflammatory action for external use
ATX code
Betamethasone in combination with antibiotics
Dosage
0.05% + 0.1% x 30g
Structure
1 g: betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg gentamicin (in the form of sulfate) 1 mg
Excipients: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, soft white paraffin, liquid paraffin, macrogol cetostearate, cetostearyl alcohol (60% cetyl alcohol, 40% stearyl alcohol), sodium hydroxide, water.
Indications
Dermatoses, allergic and inflammatory skin diseases that respond to topical corticosteroid therapy, the course of which is complicated by a bacterial infection or there is a danger of its addition in children from 1 year of age and in adults:
eczema, diffuse neurodermatitis
dermatitis atopic, contact (including professional), allergic, seborrheic
Infected dermatitis resulting from insect bites
impetigo
psoriasis
lichen planus
phleboderma
anogenital itching.
INN / Active ingredient
betamethasone, gentamicin (sulfate form)
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 4 years
Contraindications
hypersensitivity to betamethasone, gentamicin and other components of Belogent
viral skin infections, skin post-vaccination reactions
open wounds, trophic ulcers
acne vulgaris, rosacea
chickenpox
cutaneous manifestations of syphilis
lupus.
Specifications
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Cream
Manufacturer country
Croatia
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
1 year
Way of introduction
Outwardly
,
On the skin
Vacation conditions
Without recipe
Brand name
Belupo
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07CC01 Betamethasone, in combination with antibiotics
Dosage form
Cream for external use
Packaging
Box
Expiration date in days
1095
The target audience
Children
Package weight, g
thirty
Mode of application
:
The drug is intended for external use only.
A cream or ointment for external use is applied to the affected area with a thin layer in the amount necessary to cover the affected surface, 2 times / day, gently rubbing.
On areas with denser skin (for example, elbows, palms and feet), as well as places from which the drug is easily erased, Belogent can be applied more often.
The duration of a continuous course of treatment is usually no more than 4 weeks.
To prevent relapses in the treatment of chronic diseases, therapy should be continued for some time after the disappearance of all symptoms.
Repeated courses of therapy are possible during the year.
A cream for external use is used for the treatment of acute, incl.
weeping skin lesions.
Ointment for external use is intended for the treatment of subacute and chronic dermatoses, incl.
dry, lichenised and scaly lesions.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + antibiotic aminoglycoside
Dosage (volume) of the substance in the preparation
:
1 g: betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg, gentamicin (in the form of sulfate) 1 mg